Carole Ho

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

DNLI

Current role

RPRX

Current role

Board Member

2025-07-17–present

BEAM

Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer and Head of Development (until November 14, 2025)	$483,000	—	$1,151,867	$2,180,003	—	$14,000	$3,828,870
2024	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$535,600	$337,416	$1,092,128	$2,043,815	—	$13,800	$4,022,759
2023	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$520,000	$269,093	$1,136,146	$2,230,744	—	$13,200	$4,169,183
2022	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$500,000	$225,000	$2,307,095	$2,647,757	—	$12,200	$5,692,052
2021	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$473,616	$284,170	$2,125,800	$3,648,420	—	$11,600	$6,543,606
2020	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$457,600	$366,080	$1,382,774	$2,107,493	—	$11,400	$4,325,347
2019	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$440,000	$176,000	$305,830	$1,558,941	—	$8,800	$2,489,571
2018	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$423,124	$371,187	$179,673	$2,948,616	—	$12,869	$3,935,469
2017	Denali Therapeutics Inc. (DNLI)	Chief Medical Officer	$406,850	$203,425	—	$746,025	—	$11,697	$1,367,997

Earnings-call appearances and filed executive appointments or departures, newest first.